0
Critical Situations |

Paradoxical Venous Limb Gangrene Complicating Oral Anticoagulation in a Patient With Cancer-Associated Deep Venous Thrombosis

Sophie Georgin, MD; Jacques Pouchot, MD; Franck Raschilas, MD; Stéphane Barete, MD; Dominique Lebret Lerolle, MD; Philippe Vinceneux, MD
Arch Dermatol. 2003;139(9):1126-1128. doi:10.1001/archderm.139.9.1126.
Text Size: A A A
Published online

Extract

Lorimer  JWSemelhago  LCBarber  GG Venous grangrene of the extremities. Can J Surg. 1994;37379- 384
PubMed
Perkins  JMTMagee  TRGalland  RB Phlegmasia caerulea dolens and venous gangrene. Br J Surg. 1996;8319- 23
PubMed
Warkentin  TEElavathil  LJHayward  CPMJohnston  MARussett  JIKelton  JG The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997;127804- 812
PubMed
Warkentin  TE Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann Intern Med. 2001;135589- 593
PubMed
Battey  PMSalam  AA Venous gangrene associated with heparin-induced thrombocytopenia. Surgery. 1985;97618- 620
PubMed
Bergqvist  DHallböök  T Development of venous gangrene during adequate anticoagulation. Vasa. 1979;8337- 338
PubMed
Bülow  SSager  P Venous gangrene. Acta Chir Scand. 1975;141272- 278
PubMed
Hirsch  J Oral anticoagulant drugs. N Engl J Med. 1991;3241865- 1875
PubMed
Roncato  MBillaud-Mesguich  EFiessenger  JNVitoux  JFAiach  MAlexandre  JM Anticoagulant treatment with fluindione: relation between the decrease of vitamin K-dependent factors and blood fluindione. Therapie. 1986;41203- 206
PubMed
Hellemans  JVorlat  MVerstraete  M Survival time of prothrombin and factors VII, IX, and X after completely synthesis blocking doses of coumarin derivatives. Br J Haematol. 1963;9506- 512
Vigano  SMannucci  PMSolinas  SBottasso  BMariani  G Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy. Br J Haematol. 1984;57213- 220
PubMed
Harrison  LJohnston  MMassicotte  MPCrowther  MMoffat  KHirsh  J Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med. 1997;126133- 136
PubMed
Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.

Venous grangrene of toes and left forefoot. Pedal pulses were palpable. The patient was managed conservatively and healed gradually with minimal loss of substance and without the need for amputation.

Grahic Jump Location
Place holder to copy figure label and caption
Figure 2.

Venous limb gangrene and current thromboembolic events in a patient with adenocarcinoma of unknown origin. DVT indicates deep venous thrombosis; INR, international normalized ratio; LMWH, low-molecular-weight heparin; PE, pulmonary embolism; and UH, unfractionated heparin.

Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com